FDA urges patients to ditch vulnerable insulin pumps built by Medtronic
A vulnerability in an insulin pump made by medical device vendor Medtronic could allow a hacker to change the pump’s settings and control the delivery of the hormone, the Food and Drug Administration warned Thursday. After security researchers demonstrated how an attacker could abuse a radio frequency protocol, which the pump uses to communicate with other devices, to inject and intercept data, the FDA told patients to switch to pump models with better cybersecurity protections. The advisory is the latest example of a health care company struggling to secure medical technology, which often is expensive and difficult to replace. Norman “Ned” Sharpless, acting head of the FDA, said the agency wasn’t aware of any patient harm stemming from the software vulnerability. While we are not aware of any patients who may have been harmed by this particular cybersecurity vulnerability, the risk of patient harm if such a vulnerability were left unaddressed is significant. — […]
The post FDA urges patients to ditch vulnerable insulin pumps built by Medtronic appeared first on CyberScoop.
Continue reading FDA urges patients to ditch vulnerable insulin pumps built by Medtronic